Cue Biopharma is trading at $27.64 (-9.09%) today following a sharp pullback from its July 30 close of $30.40, despite a lack of clear company-specific news.
- No company-specific announcements or earnings releases were found to explain the move, suggesting the decline may be driven by technical factors or order flow.
- The downward move appears isolated to the stock, as the broader market is showing risk-on sentiment with the Nasdaq Composite up 1.39% in pre-market conditions.